CPHI Milan 2026
10/2026 – 10/2026
회사 소개
- 법인명: Yuxi Walvax Biotechnology Co., Ltd.
- 등록 국가: China
- 주소: 83 South Dongfeng Road, Yuxi • Yunnan
- 직원 수: 1000 - 4999
- 설립 연도: 2001
설명:
Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in researching, developing, manufacturing and distributing safe, efficacious human vaccines. A leading publicly listed company in China, Walvax has successfully developed 9 licensed vaccines (13 presentations), including the world's 2nd approved PCV-13 vaccine, 4th approved mRNA COVID-19 vaccine, and 5th approved HPV vaccine.
사업 활동
바이오의약품
수출업체제조업체
ATC 분류체계 (해부치료화학분류)
제조업체
판매 시장
- South Asia: Bangladesh, India
- Mainland Southeast Asia: Indonesia, Philippines
- Central Asia: Kyrgyzstan, Uzbekistan
- Northern Africa: Egypt, Morocco
- Western Africa: Nigeria, Senegal
당사 제품 & 서비스
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
증거
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기